In the article, “Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature,” by Felipe Soto et al (Journal of Immunotherapy and Precision Oncology. 2023;6:111–116. DOI: 10.36401/JIPO-22-30), two coauthors were inadvertently excluded from the list of authors. The corrections are shown below in bold.

Felipe Soto,1,2 Luis F. Torre-Sada,1,2 Frank E. Mott,3 Sang T. Kim,4 Roza Nurieva,5Priyadharsini Nagarajan,6 Ming Guo,6 Vickie R. Shannon,1 Saadia A. Faiz,1 Roberto F. Casal,1 Mehmet Altan,3 Julie Lin,1 Ajay Sheshadri1

1Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

2School of Medicine, Tecnologico de Monterrey, Monterrey, Mexico

3Department of Thoracic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

4Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

5Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

6Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA